http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2007123941-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_24e76490bed88751680a5fef9bc73892
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5aab8545f4b13c193dabb45f09bfca2e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5df9f1a7f9969f34f2afc1b363b3f7e1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_562961cf0d7aa8baf98764e53bef166a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1514f8400515cfafe06e9d9523b3de34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8861af5966f9ec960eb4943ec95828c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10560d784c97f424e31b94875a665c32
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D311-58
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D311-58
filingDate 2007-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1281be04c5f70b18679327e7dd743336
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b3d1706d880dc1722efac596d69dfd3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a24063c0ebc82c89cae4670305aeecb0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d62bd86243fa9c04bd37ae4046baa066
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4a82e0f560279f75d93d9561f7e45180
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b04d2c9c5a56bda19d951c45c88f8759
publicationDate 2008-01-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2007123941-A3
titleOfInvention Chromane and chromene derivatives and uses thereof
abstract Methods of preparing compounds of formula (I) or pharmaceutically acceptable salts thereof are provided wherein each of R1, R2, R3, R4, x, m, n, and Ar are as defined, and described in classes and subclasses herein, which are agonists or partial agonists of the 2C subtype of brain serotonin receptors. The compounds, and compositions containing the compounds, can be used to treat a variety of central nervous system disorders such as schizophrenia.
priorityDate 2006-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0005217-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003100579-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006116165-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005056544-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9505383-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1445324-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136319
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425701257
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5202
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394200

Total number of triples: 33.